Table 1.
Period | screening | F/U | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Visit | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 |
Week | 1st | 2nd | 3rd | Visit10+ 1 week+ 3 days |
|||||||
Informed consent | ν | ||||||||||
Demographic characteristics | ν | ||||||||||
Medical History | ν | ||||||||||
Physical examination | ν | ||||||||||
Random Allocation | ν | ||||||||||
Acupuncture Treatment | ν | ν | ν | ν | ν | ν | ν | ν | ν | ||
Symptom score | ν | ν | ν | ν | ν | ν | ν | ν | ν | ν | ν |
OSDI | ν | ν | ν | ν | ν | ||||||
Schirmer I test | ν | ν | |||||||||
TFBUT | ν | ν | |||||||||
MQS | ν | ν | ν | ν | ν | ν | ν | ν | ν | ν | |
General assessment (patient/doctor) |
ν | ||||||||||
Blinding Assessment | ν | ν | |||||||||
Safety Assessment | ν | ν | ν | ν | ν | ν | ν | ν | ν | ν |
OSDI: Ocular Surface Disease Index; TFBUT: Tear Film Break-up Time; MQS: Medication Quantification Scale